Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middl...
Q2 2026
Aug 5, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 5, 2025